Skip to main content

Whipping out the wiggly

Last month, Asa celebrated his third birthday. On the same day, he started to write. He didn’t write much -- the words were dog and van. But if you saw him write them, you’d notice the pleasure he took in it -- in the alchemy of turning letters into living, moving things.

A little over a year ago, when his second birthday was approaching, he’d had a massive relapse. A week later he had a Hickman line inserted -- a sort of artificial umbilicus that provides easy access to the bloodstream -- in preparation for chemo. And although the chemo treatment lasted only four months, the line was left in, just in case more chemo, or radiation therapy, were called for.

Three weeks ago he had his Hickman line removed. The operation was carried out at Great Ormond Street Hospital, and it was fast. In a matter of hours we were on our way home again, and our little boy was no longer trailing rubber piping.

Naming the numbers on the hospital gown. 15 minutes later the wiggly was whipped out.

The absence of the Hickman line (or ‘wiggly’ as it’s often called) means Asa can start to do some things that children often enjoy, that have been off-limits to him for the last year. Like swimming. Or just splashing around in the bathtub. (The wiggly is vulnerable to infection, and has to be kept dry.)

And his dad doesn’t have to worry so much any more when he’s rough-housing.

More significantly, the doctors’ decision to remove the wiggly reflects some confidence that he may remain stable for a while.

A play therapist models breathing gas through a face mask before Asa’s most recent exam under anaesthetic.

The treatments Asa’s receiving now --  cryo and laser therapy -- are largely succeeding in keeping the tumours under control. Every three weeks, when he goes under anaesthetic, the doctors see new areas of activity; but for the past few months they have been small, and in parts of the eye that are easily accessible to treatment.

In comparison with the diagnosis that preceded his first birthday, and the relapse that overshadowed his second, this is good news indeed.


Popular posts from this blog


Maybe it's all the to-and-fro'ing we've done on the trains between London and Birmingham for his eye exams, or maybe it's due to some kind of innate fascination with large moving things, but Asa loves trains.

I post these drawings of his partly to cheer myself up. It's been a pretty rough week, watching the US elect a con man as President.

Asa is an American citizen, and in 13 years time he'll be eligible to vote. I'm grateful that he's healthy, and that he stands an excellent chance of living a full life. But I worry about the world that he and his generation will inherit.

Let us pray for wisdom in our leaders, and for strength and resolve for those who resist them in the cause of the greater good.

Blind for a day

My mum likes to say that we learn about our bodies the way we learn about cars -- each time something goes wrong, you get acquainted with a new branch of mechanics.

As various treatments have been tried out on Asa, we've learned more and more about cancer and the eye.

The graph below summarises the treatments Asa's received these past 18 months.

Situations where retinoblastoma fails to respond to both primary and secondarychemo are rare, and even at one of the world's specialist treatment centres, a doctor might see such a case only once every few years.

 Support research on eye cancer here.
Right now we're in a place, therefore, where epidemiology and large trials have ceased to help much, and clinical judgment becomes very important.

As Dr Jenkinson -- the oncologist we met with in Birmingham -- said, "We're beyond the situation where there's a firm evidence base."

What's required then is very close attention to the details of the disease as it'…

Mixed results

Last Wednesday Asa was put to sleep and underwent an eye exam under anaesthetic. 
The first since the beginning of the new chemo, the exam showed that the drugs have had a "partial effect."

In Asa's left eye, the tumours responded well to the chemo. 
But in the right eye, there's been a slight increase in tumour activity.
And in the left eye there's a cataract developing.
A mixed bag
This was not what we'd hoped to hear.
We had reason to expect that the TVD (topotecan-vincristine-doxorubicin) combination would lead to shrinkage of the tumours in both eyes. 
And the appearance of a cataract -- a clouding of the lens -- at this stage is unusual: puzzling to the doctors as well as us.
While cataracts can be removed through surgery, cutting into the eye when there are active tumours inside is not advisable. So treatment for the cataract itself will have to wait until the tumours are stable.
The main risk in the near future is that the cataract may make it difficult to moni…